A single-center retrospective case review to assess the potential impact of coadministration of acid-suppressing therapy with sorafenib in patients with advanced HCC
Latest Information Update: 25 Jul 2021
At a glance
- Drugs Sorafenib (Primary) ; Antacids
- Indications Liver cancer
- Focus Therapeutic Use
- 25 Jul 2021 New trial record